GlassScriptPhysician profile
Timothy M Daly
NPI 1003074006
$1,059.70
in general payments reported to CMS, 2019-2025
18 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.89 · 2021: $39.48 · 2022: $29.97 · 2023: $171 · 2024: $346 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $976.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $381.68 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $98.40 | 2024-2025 | |
| Pfizer INC. | $84.33 | 2023-2025 | |
| Astellas Pharma US INC | $80.36 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $62.23 | 2023-2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $46.18 | 2024-2025 | |
| Lundbeck LLC | $38.88 | 2023-2024 | Rexulti |
| Glaxosmithkline, LLC. | $38.36 | 2021-2025 | Trelegy Ellipta |
| Alkermes, INC. | $38.00 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $36.42 | 2023-2025 | Airsupra, Breztri |
| Electromed, INC. | $29.97 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.04 | 2025 | Xifaxan |
| Abbott Laboratories | $21.59 | 2024 | Freestyle Libre 3 |
| Daiichi Sankyo INC. | $20.14 | 2023 | Injectafer |
| Lilly USA, LLC | $16.00 | 2025 | Mounjaro |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $14.88 | 2023 | Sublocade |
| Merck Sharp & Dohme LLC | $14.72 | 2025 | Capvaxive, Gardasil 9 |
| Braeburn INC. | $14.52 | 2023 | Brixadi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Daly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.